Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Thomas Walther , Johannes Blumenstein Added: 3 years ago
During the past five years, transcatheter (T) aortic valve implantation (AVI) has evolved as one of the most important clinical innovations in cardiovascular disease. The specific merit of TAVI is to allow for minimally invasive treatment of severe symptomatic aortic stenosis (AS) in elderly and high-risk patients. Since 2005 retrograde transfemoral (TF) and antegrade transapical (TA) aortic… View more
Author(s): Alain Cribier Added: 3 years ago
Due to the ageing population and the consequent increased prevalence of aortic stenosis,1 the management of this disease in elderly patients, especially when associated with complex co-morbidities, is becoming an important issue for physicians. While surgical valve replacement remains the ‘gold standard’ treatment, operative mortality and morbidity increase with age and become significantly… View more
Author(s): Kendra J Grubb , Suzanne J Baron Added: 1 year ago
Bringing surgery and interventional cardiology together, Dr Suzanne Baron (Lahey Health, US)and her team published a review article on “The Evolving Role of the Multidisciplinary Heart Team in Aortic Stenosis”, in a comprehensive special focus issue on the “Lifetime Management of Patients With Aortic Stenosis” edited by Dr Kendra Grubb (Emory Structural Heart and Valve Center, US). In this… View more
Author(s): Ole De Backer , Darren Mylotte , Colum Owens , et al Added: 2 years ago
In this symposium, part of Transcatheter Interventions Online 2022, Dr Colum Owens and Prof Mark Spence from Royal Victoria Hospital, Belfast perform a TAVI implantation with a focus on preserving future coronary access. Before the live case, Prof Ole De Backer and Dr Darren Mylotte will present on current trends in TAVI and key considerations for first choice valve in low-risk populations. … View more
Added: 4 years ago
In this video series chairs, Prof Simon Redwood (Guy’s and St Thomas’ NHS Foundation Trust, London, UK) and Dr Clare Appleby (Liverpool Heart and Chest Hospital, Liverpool, UK) ask the question “Should TAVI be the default treatment for patients with symptomatic aortic stenosis?". From BCIS ACI’s audience and introducing the panel of the debate. Further through the seriesProf David Hildick-Smith … View more
Author(s): John Forrest Added: 1 year ago
ACC.23/WCC - We are joined onsite by Dr John Forrest (Yale Valve Clinic, US) in this short video, who outlines the three-year outcomes of the Evolut Low-Risk Trial(Medtronic Cardiovascular) (NCT02701283). This study aimed to compare transcatheter aortic valve replacement (TAVR) using Medtronic's TAVR valve with surgical aortic valve replacement (SAVR) in over 2000 patients with aortic stenosis… View more
Added: 1 year ago
TCT 22 - Prof Helge Möllmann joins us to discuss the findings of a study that aimed to evaluate the procedural safety and device performance of Abbott's Portico™ TAVI Valve in patients with severe symptomatic degenerative aortic stenosis. Originally presented at TCT 22, The CONFIDENCE Registry involved over 1000 patients with NYHA Class ≥ II Aortic Stenosis who received transcatheter aortic… View more
Author(s): Jose Luis Zamorano , Rebecca T Hahn , Patrizio Lancellotti , et al Added: 2 years ago
In this on-demand programme,a world-renowned faculty led byProgramme ChairProf José Luis Zamorano (University Complutense, Spain) and Scientific Director Dr Rebecca THahn(New York-Presbyterian / Columbia University Medical Center, US), explore tips, tricks and expert insight to optimise echocardiographic image acquisition strategies to support earlier diagnosis and improved patient outcomes. … View more